{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T12:10:15Z","timestamp":1751458215191},"reference-count":30,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":203,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2001,6]]},"abstract":"<jats:p><jats:bold>Background<\/jats:bold> Lipoprotein(a) [Lp(a)] is an atherothrombotic plasma lipoprotein with unknown function. Little is known about the catabolism of this lipoprotein, in particular the steps related to apolipoprotein(a) [apo(a)] fragmentation and excretion by the kidney.<\/jats:p><jats:p><jats:bold>Material and methods<\/jats:bold> High plasma levels (up to 9\u2003mg\u2003dL<jats:sup>\u22121<\/jats:sup>) of the N\u2010terminal fragment of apo(a) were expressed in mice by adenovirus mediated gene transfer. Plasma of such N\u2010apo(a) mice was injected into acceptor mice and the fragmentation and urinary secretion of N\u2010apo(a) were followed by immunochemical techniques.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> Mice transduced with N\u2010Ad expressed apo(a)\u2010fragments with 3\u201311 kringle\u2010IV (KIV) repeats. Injection of N\u2010apo(a)\u2010plasma from donor mice into acceptor mice resulted in fragmentation of N\u2010apo(a)s with 3\u201311 KIVs yielding smaller peptides down to 2 KIVs. Secretion of N\u2010apo(a)\u2010fragments with 2 to maximally 6 KIVs into urine occurred as early as 2\u2003min after injection. Immunohistochemical studies of kidney suggested filtration as a mechanism of apo(a)\u2010fragment excretion.<\/jats:p><jats:p>When N\u2010apo(a) was incubated <jats:italic>in vitro<\/jats:italic> with various tissues from perfused mice, skeletal muscle and kidney followed by liver and spleen contributed to fragmentation. Tissues from unperfused organs, or the addition of normal mouse plasma, caused marked reduction in N\u2010apo(a) fragmentation. EDTA, and not aprotinin or leupeptin, prevented apo(a) cleavage.<\/jats:p><jats:p><jats:bold>Conclusion<\/jats:bold> Here we provide evidence that apo(a) is cleaved by metalloproteinases located on skeletal muscle, kidney and other organs. Small apo(a)\u2010fragments up to a size of 6 KIVs are excreted into urine, yet a major portion of apo(a) fragments is removed from circulation extrarenally.<\/jats:p>","DOI":"10.1046\/j.1365-2362.2001.00811.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T15:52:29Z","timestamp":1047397949000},"page":"504-512","source":"Crossref","is-referenced-by-count":18,"title":["Role of various tissues in apo(a) fragmentation and excretion of fragments by the kidney"],"prefix":"10.1111","volume":"31","author":[{"given":"S.","family":"Frank","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hrzenjak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Blaschitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Dohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. M.","family":"Kostner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1093\/clinchem\/44.11.2301","article-title":"Lipoprotein (a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies","volume":"44","author":"Craig WY","year":"1998","journal-title":"Clin Chem"},{"key":"e_1_2_6_3_2","volume-title":"The metabolic, molecular bases of inherited disease.","author":"Utermann G","year":"1995"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/330132a0"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/B978-0-12-620990-7.50007-3","volume-title":"Lipoprotein (a).","author":"Morrisett J","year":"1990"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/2.7.933"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/2.4.361"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109813"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.50.32403"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1996.112255.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"28716","DOI":"10.1016\/S0021-9258(19)61964-2","article-title":"Cell surface assembly of lipoprotein (a) in primary cultures of baboon hepatocytes","volume":"269","author":"White AL","year":"1994","journal-title":"J Biol Chem"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110896"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.11.4171"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.13.7.1101"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119753"},{"key":"e_1_2_6_16_2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0022-2275(20)37595-7","article-title":"Interaction of a recombinant form of apolipoprotein (a) with human fibroblasts and with the human hepatoma cell line","volume":"37","author":"Tam S\u2010P","year":"1996","journal-title":"J Lipid Res"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0022-2275(20)37140-6","article-title":"Cellular uptake of lipoprotein (a) by mouse embryonic fibroblasts via the LDL receptor and the LDL receptor\u2010related protein","volume":"38","author":"Reblin T","year":"1997","journal-title":"J Lipid Res"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.19.3.552"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1098-1098(199624)7:4<271::aid-ima2>3.0.co;2-5"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0022-2275(20)37150-9","article-title":"Renovascular arteriovenous differences in Lp (a) plasma concentrations suggests removal of Lp (a) from the renal circulation","volume":"38","author":"Kronenberg F","year":"1997","journal-title":"J Lipid Res"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1093\/clinchem\/38.11.2244","article-title":"Apolipoprotein (a) is present in urine and its excretion is decreased in patients with renal failure","volume":"38","author":"Oida K","year":"1992","journal-title":"Clin Chem"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118487"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.16.8.905"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00206a041"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.12.6852"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(88)90302-9"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(73)90341-3"},{"key":"e_1_2_6_28_2","doi-asserted-by":"crossref","first-page":"29395","DOI":"10.1016\/S0021-9258(18)43892-6","article-title":"Adenovirus\u2010mediated gene transfer of a rat apolipoprotein B mRNA\u2010editing protein in mice virtually eliminates apolipoprotein B\u2010100 and normal low density lipoprotein production","volume":"269","author":"Teng B","year":"1994","journal-title":"J Biol Chem"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-1981(99)00044-X"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.15.10019"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.19.4.1060"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2362.2001.00811.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2362.2001.00811.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2362.2001.00811.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T13:46:07Z","timestamp":1695735967000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2362.2001.00811.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["10.1046\/j.1365-2362.2001.00811.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2362.2001.00811.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}